Coldstream Capital Management Inc. Sells 699 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Coldstream Capital Management Inc. lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,825 shares of the biotechnology company's stock after selling 699 shares during the quarter. Coldstream Capital Management Inc.'s holdings in Axon Enterprise were worth $4,056,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in AXON. Vanguard Group Inc. lifted its stake in Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Axon Enterprise by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock worth $1,095,542,000 after acquiring an additional 65,097 shares during the last quarter. Capital World Investors boosted its holdings in Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock valued at $1,079,145,000 after acquiring an additional 841,772 shares during the period. Alliancebernstein L.P. grew its position in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after acquiring an additional 812,337 shares during the last quarter. Finally, Norges Bank purchased a new stake in Axon Enterprise in the fourth quarter worth $482,081,000. Institutional investors own 79.08% of the company's stock.

Insider Buying and Selling

In related news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 2.2 %

Shares of NASDAQ AXON opened at $603.78 on Friday. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The stock's fifty day simple moving average is $545.51 and its two-hundred day simple moving average is $571.68. The stock has a market capitalization of $47.00 billion, a PE ratio of 156.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AXON shares. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $626.45.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.